ArticlePatient preference and adherence2025
Risk Factors Affecting Quality of Life in Chronic Limb Threatening Ischemia Patients.
Article in Patient preference and adherence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To analyze the independent risk factors affecting quality of life (QoL) in chronic limb threatening ischemia (CLTI) patients, with a particular focus on the role of the Wound, Ischemia, and foot Infection (WIfI) classification. Understanding these relationships could provide insights into optimizing patient management and improving their overall QoL. Patients and Methods: This study was conducted at our center from January 2021 to January 2024. Hospitalized patients diagnosed with CLTI (Rutherford categories 4-6) were enrolled for QoL assessment using the Vascular Quality of Life Questionnaire (VascuQoL). We analyzed the differences in the scores of vascuQoL and its five dimensions among patients grouped by different WIfI stages. A linear regression model was used to identify independent risk factors of overall VascuQoL scores and its different dimensions. Results: This study included 309 patients with an average age of 70.11 years; 30.1% were female. The mean baseline VascuQoL score was 2.02 ± 0.83. According to the WIfI classification, patients were distributed as follows: 15.53% stage 4, 39.16% stage 3, 27.83% stage 2, and 17.48% stage 1. WIfI classification emerged as a key independent predictor, significantly affecting overall VascuQoL scores (β=-0.15, 95% CI -0.24 to -0.06, P=0.002) and four out of five QoL dimensions (activity, symptoms, emotional well-being, and social interactions). Female sex, smoking history, cerebral infarction history, and previous limb revascularization also affect the quality of life from different dimensions or as a whole. Conclusion: CLTI markedly worsens patients' QoL, with WIfI stage playing a crucial role in determining outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.